On 5-6 February, over 500 leading lights, emerging stars, C-suite executives, impactful investors and powerful stakeholders will attend the 4th annual Biotech and Money/Medtech and Money World Congress.
London, January 23, 2018
On 5-6 February, over 500 leading lights, emerging stars, C-suite executives, impactful investors and powerful stakeholders will attend the 4th annual Biotech and Money/Medtech and Money World Congress. The congress is a high-calibre, senior executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective investment, business planning, and partnering within their businesses.
In just three years, the congress has become the go-to event for life science executives looking to engage in investment and partnering with many of the world’s leading funds. The congress brings together the people that matter to the future of healthcare and life sciences.
Terence O’Dwyer, Co-CEO at Biotech and Money, said: “The congress is now a firm date in people’s diaries and we’re delighted to continue to provide a platform in which senior executives are able to access the intelligence, capital, and partners companies need to grow their businesses.
“There are few occasions in a year when life science executives have the opportunity to engage in such high-level networking with their peers. The 2018 Biotech and Money/Medtech and Money World Congress is one of those occasions and we look forward to providing the platform they deserve.”
To find out more and to secure your place, please visit http://www.biotechandmoney.com/world-congress.
